Abstract
Heart failure is the leading cause of human death in the world, and current surgery delay progressive diseases, but not permanent solution for clinical approaches. New investigating strategy for regenerative medicine will be that transplanting stem cell/iPS cell based cardiac cells will accelerate clinical applications. Therefore, the significant research is to know the molecular mechanisms for specification of individual cardiac cell fate, and to identify the molecules inducing individual cell fate.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.